Lumida
/EPC
⌘K
Edgewell Personal Care Co

Edgewell Personal Care Co

EPC
$26.93USD+0.19%+0.05 today

MARKET CAP

1.2B

P/E (TTM)

FWD P/E

DAY RANGE

$26 – $27

52W RANGE

$16
$30

AI Summary

Stalk
Sell NowMedium

The asset has shifted into a pronounced sell-off following support failures and bearish pivot confirmation, indicating that sellers dominate. Medium-term bias is bearish due to accelerated downward momentum, with structural repair underway after price broke below 9/20 EMAs and 50 SMA on heavy volume. Short-term bias is bearish with no significant rejection or divergence, suggesting timing favors selling now. Tactical entries focus on retests of broken support zones if any relief rally emerges.

  • Organic net sales rose 1.1% YoY in Q3 2026, led by North America.
  • Cremo brand sustained over 20% sales growth for seven straight quarters.
  • Adjusted EPS remained flat at $0.72 YoY, indicating profit stagnation.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.1B$2.2B$2.3B$2.3B$2.2B
YoY %+7.1%+4.0%+3.7%+0.1%-1.3%
P / Sales1.0x0.9x0.8x0.8x0.4x
EV / Sales1.7x1.9x1.7x1.7x1.3x
Gross Profit, Adj.$951.2M$880.5M$940.8M$955.7M$924.9M
YoY %+8.0%-7.4%+6.8%+1.6%-3.2%
Margin %45.6%40.5%41.8%42.4%41.6%
EV / Gross Profit3.8x4.6x4.1x3.9x3.2x
EBITDA, Adj.$347.8M$287.5M$335.0M$323.2M$284.4M
YoY %+20.2%-17.3%+16.5%-3.5%-12.0%
Margin %16.7%13.2%14.9%14.3%12.8%
EV / EBITDA10.4x14.1x11.6x11.6x10.4x
EBIT$239.9M$182.3M$227.0M$199.3M$96.6M
YoY %+36.3%-24.0%+24.5%-12.2%-51.5%
Margin %11.5%8.4%10.1%8.8%4.3%
EV / EBIT15.1x22.3x17.0x18.9x30.5x
Net Income$117.8M$99.5M$114.7M$98.6M$25.4M
YoY %+74.3%-15.5%+15.3%-14.0%-74.2%
Net Margin5.6%4.6%5.1%4.4%1.1%
EPS (GAAP)$2.13$1.85$2.21$1.97$0.53
YoY %+71.8%-13.1%+19.5%-10.9%-73.1%